Partner Content Partner Content Talks from the MHRA, Innovate UK, Plasticell and more Cell and Gene Therapy
Events Partner Content 16th Pharmacovigilance 2018 16th Pharmacovigilance 2018 “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management"
Partner Content Partner Content Gene Therapy bringing new hope to patients and families Ophthalmic Drugs
Partner Content Partner Content Targeting Solid & Liquid Malignancies with the Same CAR Cell and Gene Therapy
Partner Content Partner Content Optimization of Lyophilization and alternatives to conventio... SMi Group reports: Alina Alexeenko of Purdue University presenting LyoHub's overview and strategies for the future of lyophilization and alternatives to conventional methods
Partner Content Partner Content W. J. Wiess and A.S. Lynch invitation to Superbugs & Sup... SMi Group reports: William J.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
